West China-Frontier Pharma Tech Co., Ltd. – FDA Inspection, Apr 21, 2017

Record Details

This FDA Inspection record concerns West China-Frontier Pharma Tech Co., Ltd., with an inspection on April 21, 2017, issued by the Office of Inspections and Investigations, covering human drugs.

Company: West China-Frontier Pharma Tech Co., Ltd.
Inspection Date: April 21, 2017
Product Type: Human Drugs
Office: Office of Inspections and Investigations
People: Carmen Y. Fisher (FDA Associated Person)
Mark J. Seaton (Company Rep)
Zhou Chen (Company Rep)

View Company Profile

ID · 61fc7636-b67a-49be-8931-f172826c56be

Inspection Facts

Inspection number: 1027031
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore West China-Frontier Pharma Tech Co., Ltd.

FDA Inspection

West China-Frontier Pharma Tech Co., Ltd.April 21, 2017

West China-Frontier Pharma Tech Co., Ltd. – FDA Inspection, Apr 21, 2017

Record Details

This FDA Inspection record concerns West China-Frontier Pharma Tech Co., Ltd., with an inspection on April 21, 2017, issued by the Office of Inspections and Investigations, covering human drugs.